MM&M Awards Finalists 2005 - Revealed

Share this article:

Revealed here for the first time are the finalists for the MM&M Awards 2005, as judged by our independent panel of industry executives.
The overall Winners and Honorable Mentions for each category will be announced at a spectacular awards presentation dinner at Tavern on the Green in New York, November 9th.

For information and tickets, please contact Jennifer Burke at (646) 638-6021 or email jennifer.burke@haymarketmedia.com. Comprehensive coverage of the finalists and the judging process, along with a look ahead to the presentation ceremony, will appear in the September issue of MM&M.

Sponsors to date:
Anderson DDB
Donahoe Purohit Miller
Integrated Communications
Millward Brown
Regan Campbell Ward
Wishbone/ITP


Best Media Buying or Planning

  • CMI-Communications Media, Inc. and Alcon Laboratories for Patanol -- Patanol 2005 NCO Media Plan
  • Starcom USA and Aventis for Lantus -- Lantus: Educate, Inspire & Motivate Advertorial Series

Healthcare Consumer Publication of the Year

  • converse
  • Every Woman: The Essential Guide for Healthy Living
  • Health
  • Caring Today Magazine
  • Fitness

Healthcare Business Publication of the Year

  • Endocrine Today
  • Irritable Bowel Syndrome Benchmarks
  • Diversion Magazine
  • Community Oncology
  • National Lipid Education Council

Healthcare Website of the Year

Best Use of Direct Marketing to Consumers

  • Healthcare Communications Group -- The Big M
  • Healthcare Communications Group -- Fight For It
  • Saatchi & Saatchi Consumer Healthcare and AstraZeneca for Seroquel -- Seroquel Adherence Program (OutREACH)
  • The Hamilton Communications Group and Baxter BioScience for Advate -- Camp SuperFly Launch
  • Invacare Corporation -- Invacare Homefill GRO2 Program

Best Use of Direct Marketing to Healthcare Professionals

  • Forma Design, Raleigh NC and LipoScience for MMR LipoProfile -- LipoProfile Direct Sales Aid Campaign
  • Harte-Hanks and King Pharmaceuticals for Intal -- Intal "Clear the Way"
  • Jeffrey Simbrow and Associates and Altana Pharma Inc./Solvay Pharma Inc. for Pantoloc --Triathelete of GERD Therapy
  • MTI and Alcon Labs for Ciprodex -- Ciprodex eXtendrX Sales Optimization Program
  • The Hamilton Communications Group and Baxter BioScience for Advate -- Camp SuperFly Launch

Best Use of PR

  • APCO Worldwide and Pfizer for The Pfizer Share Card: Commitment to Access -- APCO Worldwide Helps Promote the Pfizer Share Card
  • Chandler Chicco Agency and Allergan, Inc. for Prevage antioxidant cream -- Prevage antioxidant cream
  • Corbett Accel Healthcare Group with HealthInfo Direct -- A Union of Equals
  • Nursing Spectrum and Johnson & Johnson for The Campaign for Nursing's Future -- They Dare to Care
  • Padilla Speer Beardsley and Acorn Cardiovascular -- Support Hose for the Heart: The CorCap Cardiac Support Device
  • Stinson Brand Innovation and Arthritis Foundation for Joints In Motion -- Evangelist Effect

Best Use of Digital Marketing to Consumers

  • Cadient Group and Ortho-McNeil Pharmaceutical, Inc. for Elmiron -- Elmiron DTC Campaign: All Aboutic.com
  • Cramer and Serono, Inc. for Fertility LifeLines -- Redesign of Fertility LifeLines Website
  • echo Torre Lazur and Cancer Institute of New Jer
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...